GSK Multiplikator Forward P/S GSK plc

Logo korporat perusahaan GlaxoSmithKline (GSK)

The GSK plc (GSK) ecosystem is based on preventive therapy and the development of critical vaccines. The issuer's forward P/S confirms the stability of this vector, while 1.30 shows the current value of this metric. Laboratory robotization is accelerating drug screening, while active M&A deals in oncology and strategic partnerships with institutes provide the synergy needed to bring unique medications to market.

GSK GlaxoSmithKline plc: Rasio kapitalisasi marang dodolan sing dikarepake ing interval 04.07.2022 - 13.11.2026

Rincian metrik komprehensif lan analitis gsk.com (GSK)

- rega saiki lan proyeksi nilai saham:
Rega saham GlaxoSmithKline|GSK - Rentang target analis
- data kapitalisasi pasar:
Kapitalisasi pasar GSK Corp|GSK - Nilai Perusahaan Nalika Diakuisisi Penuh
- statistik nilai buku emiten:
Aset Bersih saben Siji Saham GSK|GSK - Pambiji Buku Bisnis|Rasio Nilai Pasar marang Nilai Buku gsk.com|GSK - Total Aset Perusahaan
- rincian utang lan likuiditas:
Rasio Total Utang marang Ekuitas GSK plc|GSK - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas GlaxoSmithKline|GSK - Gunggung tanggungan utang perusahaan|Rasio utang marang kapitalisasi buku GSK Corp|GSK - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan GSK|Rasio cepet gsk.com
- data bathi bisnis lan rasio investasi:
GSK - Bathi resik taunan|Bathi sing dikarepake GSK plc|GSK - Periode bali modal bisnis|Rega marang bathi mangsa ngarep GlaxoSmithKline|GSK - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan GSK Corp|GSK - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi resik saben saham (EPS TTM) GSK|GSK - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan gsk.com|GSK - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep GSK plc
- indikator volume dodolan lan pendapatan:
GSK - Pendapatan dodolan perusahaan|Prakiraan pendapatan perusahaan GlaxoSmithKline|GSK - Kapitalisasi marang pendapatan|Multiplikator Forward P/S GSK Corp
Pambiji fundamental:GSK (GSK Corp)
Produk sing diprodhuksi GlaxoSmithKline

The reliability of the costly cold chain for GSK plc (GSK) vaccine delivery ensures a steady revenue stream, which is reflected in the trend of the projected market cap-to-revenue ratio. This indicator correlates the company's current market value with expected annual sales to identify the phase of the market cycle. The upward curve confirms market optimism and strengthening fundamentals, allowing investors to timely assess the asset's degree of overboughtness.

Karo sapa GSK plc saingan

Multiplikator Forward P/S LLY (Eli Lilly)|Prakiraan rega marang pendapatan AbbVie Inc|AstraZeneca AB - Multiplikator Forward P/S|Prakiraan rega marang pendapatan Novartis Pharma (NVS)|Merck & Co., Inc. (MRK) - Rasio rega marang prakiraan pendapatan|NVO - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Amgen|Multiplikator Forward P/S Pfizer Inc|Multiplikator forward rega marang pendapatan SNY (Sanofi Aventis)|BMY (Bristol-Myers Squibb Co.) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Takeda Pharmaceutical TAK|TEVA (tevapharm.com) - Rega mangsa ngarep marang pendapatan|RDY - Rasio rega marang prakiraan pendapatan|VTRS: Rasio rega marang prakiraan pendapatan|ROIV: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Zai Lab Corp|BHC (Bausch Health Companies) - Multiplikator Forward P/S|COSM - Prakiraan rega marang pendapatan